HALOGENATED QUINDOLINE DIMERS FOR THE TREATMENT OF CANCER

The invention provides quindoline dimers where at least one quindoline moiety is substituted in the 2-position of the quindoline scaffold by an halogen atom. The compounds of the invention show advantageous properties as cytotoxic agents for their use as medicaments against cancer.

Saved in:
Bibliographic Details
Main Authors AYMAMI BOFARULL, JUAN, NAVARRO MUNOZ, ISABEL
Format Patent
LanguageEnglish
French
German
Published 06.01.2010
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention provides quindoline dimers where at least one quindoline moiety is substituted in the 2-position of the quindoline scaffold by an halogen atom. The compounds of the invention show advantageous properties as cytotoxic agents for their use as medicaments against cancer.
AbstractList The invention provides quindoline dimers where at least one quindoline moiety is substituted in the 2-position of the quindoline scaffold by an halogen atom. The compounds of the invention show advantageous properties as cytotoxic agents for their use as medicaments against cancer.
Author AYMAMI BOFARULL, JUAN
NAVARRO MUNOZ, ISABEL
Author_xml – fullname: AYMAMI BOFARULL, JUAN
– fullname: NAVARRO MUNOZ, ISABEL
BookMark eNrjYmDJy89L5WSw9HD08Xd39XMMcXVRCAz19HPx9_H0c1Vw8fR1DQpWcPMPUgjxcFUICXJ1DPF19QtR8HdTcHb0c3YN4mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BhhYWpsZmJk6GxkQoAQA2pSoD
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate DIMERES DE QUINDOLINE HALOGNES POUR LE TRAITEMENT DU CANCER
HALOGENIERTE CHINDOLIN-DIMERE ZUR BEHANDLUNG VON KREBS
ExternalDocumentID EP1885364B1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP1885364B13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:15:50 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP1885364B13
Notes Application Number: EP20060763131
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100106&DB=EPODOC&CC=EP&NR=1885364B1
ParticipantIDs epo_espacenet_EP1885364B1
PublicationCentury 2000
PublicationDate 20100106
PublicationDateYYYYMMDD 2010-01-06
PublicationDate_xml – month: 01
  year: 2010
  text: 20100106
  day: 06
PublicationDecade 2010
PublicationYear 2010
RelatedCompanies CRYSTAX PHARMACEUTICALS, S.L
RelatedCompanies_xml – name: CRYSTAX PHARMACEUTICALS, S.L
Score 2.7632563
Snippet The invention provides quindoline dimers where at least one quindoline moiety is substituted in the 2-position of the quindoline scaffold by an halogen atom....
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title HALOGENATED QUINDOLINE DIMERS FOR THE TREATMENT OF CANCER
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100106&DB=EPODOC&locale=&CC=EP&NR=1885364B1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVbG-2IPkFiTNJmUPRZpkYyLNw5hKbyXZJNBLWtqIf9_J2lYvelt2YZhdmMe38wJ4MAqhC0ErtSw0XaUMfbiM0YFqMloJwYalkFmVQWh6U_oyM2YdWOxqYWSf0E_ZHBElSqC8N1Jfr34-sRyZW7l5zBe4tXxy05GjbNGxJiGO4lgjHkdOZCu2jSslTFDI0S6Z1EKgdNB60W2bff5utUUpq98WxT2FwxiJ1c0ZdMq6B8f2bvBaD46Cbbwbl1vR25wD88aT6JmHY1Q15HXqh0408UNOHD_gyRtBMEdSj5M04eO0bdBPIpfY7eSZ5AKIy1PbU5GH-f6-cx7vudUvoVsv6_IKSMGMasiywqgKk2Y6Kodcz_QBQhCWawh7-tD_k8z1P2c3cPIdEW8zoG6h26w_yjs0tE1-L5_oC5y4fJ8
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ401VhvWjXW5x4MN2JaFpo9NIbHItUCFanpjcACSS-0sRj_vsPaVi96m-wmk9lNZma_nRfAnZ4LTQhaqkXe11TK8A2XMjpQDUZLIdiwEDKr0g8Mb0af5vq8BYttLYzsE_opmyOiRgnU91ra69XPJ5YjcyvX99kCl5YPbjxylA067kuIozjWiE9DJ7QV20ZKCSJUcvRLBrUQKO0NERFKpPRmNUUpq98exT2C_Skyq-pjaBVVFzr2dvBaFw78TbwbyY3qrU-AeeYkfOSBiaaGvMzGgRNOxgEnztjn0StBMEdij5M44mbcNOgnoUvsZvJMdArE5bHtqShDsjtvwqc7abUzaFfLqjgHkjO9HLI018vcoKmGxiHTUm2AEIRlfYQ9Pej9yebin71b6HixP0lQ5udLOPyOjjfZUFfQrt8_imt0unV2I6_rC5Wqf4k
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=HALOGENATED+QUINDOLINE+DIMERS+FOR+THE+TREATMENT+OF+CANCER&rft.inventor=AYMAMI+BOFARULL%2C+JUAN&rft.inventor=NAVARRO+MUNOZ%2C+ISABEL&rft.date=2010-01-06&rft.externalDBID=B1&rft.externalDocID=EP1885364B1